pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
CX-001
Nevus
Calissa Therapeutics
0
catalysts
Preclinical
CX-01
Gastrointestinal Radiation Toxicity
Ceramedix Holding LLC
0
catalysts
Preclinical
CX-011
Osteoarthritis
CarthroniX Inc
0
catalysts
Phase 2
CX-1739
Central Sleep Apnea
Glutamate receptor ionotropic AMPA
← prev
page 74 of 231
next →
131
Pain
89
Neurology
1
EndeavourRx LLC
0
catalysts
Phase 1
CX-213
Subarachnoid Hemorrhage
Cenyx Biotech Inc
0
catalysts
Phase 2
CX-717
Attention Deficit Hyperactivity Disorder (ADHD)
EndeavourRx LLC
0
catalysts
Phase 1
CX-801
Head And Neck Squamous Cell Carcinoma (HNSC)
$CTMX
CytomX Therapeutics, Inc.
0
catalysts
Preclinical
CXR-102
Squamous Non-Small Cell Lung Carcinoma
CorriXR Therapeutics Inc
0
catalysts
Preclinical
CYC-126
Treatment Resistant Depression
$CYCN
Cyclerion Therapeutics, Inc.
0
catalysts
Phase 2
CYP-001
Graft Versus Host Disease (GVHD)
Cynata Therapeutics Ltd
0
catalysts
CYSTOGRAFIN DILUTE
CYSTOGRAFIN DILUTE (DIATRIZOATE MEGLUMINE)
BRACCO
0
catalysts
Phase 1
CYT-1010
Post-Operative Pain
Cytogel Pharma LLC
0
catalysts
Preclinical
CYT-102
Recurrent Glioblastoma Multiforme (GBM)
Cytea Bio
0
catalysts
Phase 2
CampETEC
Campylobacter Infections
$IMRN
Immuron Ltd
0
catalysts
Marketed
Camptosar
Camptosar (irinotecan hydrochloride)
Colorectal Cancer
$PFE
PFIZER INC
0
catalysts
Phase 1
Campylobacter jejuni [strain CPS81-176] vaccine
Campylobacter Infections
US Army Medical Research & Materiel Command
0
catalysts
Phase 2
Cancer Program
Metastatic Colorectal Cancer
Programmed cell death protein 1
Mirror Biologics Inc
0
catalysts
Preclinical
CannQuit-O
Opium (Opioid) Addiction
$IXHL
Incannex Healthcare Inc.
0
catalysts
Phase 1
Cantrixil
Epithelial Ovarian Cancer
Vivesto AB
0
catalysts
Phase 2
Carboxyamidotriazole Orotate
Pravitinib
Glioblastoma Multiforme (GBM)
Tactical Therapeutics Inc
0
catalysts
Phase 2
CardiALLO
Systolic Heart Failure (HFrEF)
$BCDA
BioCardia, Inc.
0
catalysts
Phase 3
CardiAMP
Myocardial Ischemia
$BCDA
BioCardia, Inc.
0
catalysts
Phase 2
Carfostin
Non-ischemic Cardiomyopathy
Asklepios BioPharmaceutical Inc
0
catalysts
Phase 2
CartiLife
Articular Cartilage Defect
Biosolution Co Ltd
0
catalysts
Phase 3
Cartistem
Osteoarthritis
MediPost Co Ltd
0
catalysts
Preclinical
Cell Therapy for Sickle Cell Disease
Sickle Cell Disease
Safi Biotherapeutics Inc
0
catalysts
Preclinical
Cell Therapy for Type 1 Diabetes
Type 1 Diabetes (Juvenile Diabetes)
University of Minnesota
0
catalysts
Phase 2
Cellular Immunotherapy for Metastatic Melanoma, Peritoneal Cancer, Fallopian Tube Cancer and Epithelial Ovarian Cancer
Metastatic Melanoma
The Chaim Sheba Medical Center
0
catalysts
Phase 1
Cellular Immunotherapy for Type 1 Diabetes
Type 1 Diabetes (Juvenile Diabetes)
Leiden University Medical Center
0
catalysts
Phase 1
Central Memory-Enriched T Cells
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
City of Hope
0
catalysts
